Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - DE
$ 4.5192
0.65 %
$ 1.6 B
Market Cap
-8.86
P/E
Price Target
Average
121.28%
Revenue Forecast
Estimate
22.50%
EBIT
Estimate
46.19%
Net Income
Estimate
40.36%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evotec SE
Wall Street analysts predict an average 1-year price target for EVO of $10 , with forecasts ranging from
a
low of
$8 to a high of $12 .
EVO Lowest Price Target
Wall Street Target
8 USD
77.02%
EVO Average Price Target
Wall Street Target
10 USD
121.28%
EVO Highest Price Target
Wall Street Target
12 USD
165.53%
REVENUE FORECAST
Revenue Forecast Chart EVO
EBIT FORECAST
EBIT Forecast Chart EVO
NET INCOME FORECAST
Net Income Chart EVO